Masayuki Okido
- Co-authors
- Masao TanakaMakoto KuboReiki NishimuraTomofumi OsakoMasaya KaiYoshinao OdaShuji ShimizuMai Yamada
- Topics
- Neuroendocrine Tumor Research Advances (4 papers)Cancer Immunotherapy and Biomarkers (4 papers)Parathyroid Disorders and Treatments (3 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEHepatology
- Partner nations
- JapanUnited StatesSwitzerland
In The Last Decade
Masayuki Okido
26 papers receiving 508 citations
Peers
Comparison fields: 5 of 69
- Oncology 271
- Surgery 170
- Pulmonary and Respiratory Medicine 144
- Molecular Biology 86
- Cancer Research 68
Countries citing papers authored by Masayuki Okido
This map shows the geographic impact of Masayuki Okido's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayuki Okido with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayuki Okido more than expected).
Fields of papers citing papers by Masayuki Okido
This network shows the impact of papers produced by Masayuki Okido. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayuki Okido. The network helps show where Masayuki Okido may publish in the future.
Co-authorship network of co-authors of Masayuki Okido
This figure shows the co-authorship network connecting the top 25 collaborators of Masayuki Okido. A scholar is included among the top collaborators of Masayuki Okido based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayuki Okido. Masayuki Okido is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 9 | |
| 3 | 18 | |
| 4 | 4 | |
| 5 | 23 | |
| 6 | 8 | |
| 7 | 21 | |
| 8 | 44 | |
| 9 | Neoadjuvant epirubicin/docetaxel (ET) concomitant chemotherapy for primary breast cancer with tumor diameter >=3.1 cm: results of the Kyushu ET therapy phase II trial. | 3 |
| 10 | 19 | |
| 11 | 15 | |
| 12 | 11 | |
| 13 | 27 | |
| 14 | 7 | |
| 15 | 11 | |
| 16 | 43 | |
| 17 | 0 | |
| 18 | 1 | |
| 19 | 4 | |
| 20 | 28 |
About Masayuki Okido
Masayuki Okido is a scholar working on Oncology, Nephrology and Cancer Research, having authored 31 papers that have together received 523 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Parathyroid Disorders and Treatments (3 papers). The work is most often cited by research in Oncology (271 citations), Cancer Research (68 citations) and Pulmonary and Respiratory Medicine (144 citations). Masayuki Okido has collaborated with scholars based in Japan, United States and Switzerland. Frequent co-authors include Masao Tanaka, Makoto Kubo, Reiki Nishimura, Tomofumi Osako, Masaya Kai, Yoshinao Oda, Shuji Shimizu, Mai Yamada, Nobuyuki Arima and Hitoshi Ichimiya. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.